Matches in Wikidata for { <http://www.wikidata.org/entity/Q66077055> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66077055 description "clinical trial" @default.
- Q66077055 description "ensayu clínicu" @default.
- Q66077055 description "klinisch onderzoek" @default.
- Q66077055 description "клінічне випробування" @default.
- Q66077055 name "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 name "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 type Item @default.
- Q66077055 label "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 label "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 prefLabel "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 prefLabel "Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status" @default.
- Q66077055 P1132 Q66077055-6C1100E1-67D6-4119-BC0D-0960554BB8F7 @default.
- Q66077055 P1476 Q66077055-C83EB59C-2D76-4F8F-B96C-AD9402CA60FA @default.
- Q66077055 P17 Q66077055-C15CEAC2-678D-4FE6-9DC1-C8F9D3E07D0F @default.
- Q66077055 P17 Q66077055-F8AC8093-279F-45DA-A48C-D86D485900F0 @default.
- Q66077055 P2899 Q66077055-1CBF9C75-AE2F-481F-A5E2-64EA21260D5E @default.
- Q66077055 P3098 Q66077055-FF7015E8-C395-49C3-9210-8EF17C1E7F59 @default.
- Q66077055 P31 Q66077055-BC251DC9-82BB-412E-810E-12486234E5A6 @default.
- Q66077055 P4135 Q66077055-245AB156-643F-4EAB-A8EC-5F7BA4818771 @default.
- Q66077055 P580 Q66077055-A529B2BE-56AC-41A7-AAFC-BE600908B5A1 @default.
- Q66077055 P582 Q66077055-278AD912-7754-4702-BD94-2F68B830EB01 @default.
- Q66077055 P6099 Q66077055-73E62831-04E0-48B7-8DC7-DB6CE083CFA5 @default.
- Q66077055 P8363 Q66077055-AB01BD5C-791F-4E24-B3DF-E384D451AD0A @default.
- Q66077055 P1132 "+272" @default.
- Q66077055 P1476 "Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects With Different HRD Tumor Status and With Platinum-Sensitive, Relapsed, High-Grade Serous or High-Grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 1 Prior Line of Chemotherapy" @default.
- Q66077055 P17 Q16 @default.
- Q66077055 P17 Q30 @default.
- Q66077055 P2899 "+18" @default.
- Q66077055 P3098 "NCT02983799" @default.
- Q66077055 P31 Q30612 @default.
- Q66077055 P4135 "+130" @default.
- Q66077055 P580 "2016-12-22T00:00:00Z" @default.
- Q66077055 P582 "2020-05-21T00:00:00Z" @default.
- Q66077055 P6099 Q42824440 @default.
- Q66077055 P8363 Q78089383 @default.